Australian biotech company Opthea has reported a solid cash position to further advance clinical trials of its lead drug candidate OPT-302 in FY20, as it moves closer to imposing itself on the macular disease market. Read more
A significant Australian study into the effectiveness of Allergan’s Ozurdex implant as a treatment for Diabetic Macular Oedema (DME) has shown positive results consistent with previously published evidence. Read more
Australian scientists have developed the world’s most detailed gene map of the human retina, providing new and unprecedented insights into the underlying determinants of retinal cell function. Read more
Five year results from the world’s longest-running clinical trial of paediatric contact lens wear has shown CooperVision’s MiSight 1 Day lens continues to slow myopia in children, even at older ages. Read more
A working group assembled by the US National Advisory Eye Council (NAEC) has called for a change in strategy among researchers investigating potential cures for atrophic age-related macular degeneration (AMD). Read more
A new research project examining the proteins that circulate in the eye’s fluids has the potential to pave the way for a test to diagnose glaucoma that doesn’t rely on intraocular pressure.
The University of New South Wales (UNSW) School of Optometry and Vision Science is currently seeking applications for 10 different Scientia PhD scholarships in eye health.
An Australian researcher has recommended against a preventative laser treatment for primary angle closure glaucoma, following an extensive study involving 900 Chinese patients. Read more
US biomedical researchers have developed a self-clearing glaucoma drainage device that uses vibration technology to disperse harmful micro-organisms. Read more
Australian eye health charity Sight For All has gone silent on its dealings with the optical chain Oscar Wylee, following revelations that several of the retailer’s philanthropic marketing claims had been called into question and refuted.